PT80237B - Processo para a metilacao selectiva de derivados de eritromicina a - Google Patents

Processo para a metilacao selectiva de derivados de eritromicina a

Info

Publication number
PT80237B
PT80237B PT80237A PT8023785A PT80237B PT 80237 B PT80237 B PT 80237B PT 80237 A PT80237 A PT 80237A PT 8023785 A PT8023785 A PT 8023785A PT 80237 B PT80237 B PT 80237B
Authority
PT
Portugal
Prior art keywords
methylacy
eritromycin
selective
derivatives
procedure
Prior art date
Application number
PT80237A
Other languages
English (en)
Other versions
PT80237A (en
Original Assignee
Taisho Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=13375748&utm_source=***_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=PT80237(B) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Taisho Pharmaceutical Co Ltd filed Critical Taisho Pharmaceutical Co Ltd
Publication of PT80237A publication Critical patent/PT80237A/pt
Publication of PT80237B publication Critical patent/PT80237B/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H17/00—Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals
    • C07H17/04—Heterocyclic radicals containing only oxygen as ring hetero atoms
    • C07H17/08—Hetero rings containing eight or more ring members, e.g. erythromycins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Saccharide Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
PT80237A 1984-04-06 1985-04-04 Processo para a metilacao selectiva de derivados de eritromicina a PT80237B (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP59068509A JPS60214796A (ja) 1984-04-06 1984-04-06 ６−０−メチルエリスロマイシン類の製法

Publications (2)

Publication Number Publication Date
PT80237A PT80237A (en) 1985-05-01
PT80237B true PT80237B (pt) 1987-06-17

Family

ID=13375748

Family Applications (1)

Application Number Title Priority Date Filing Date
PT80237A PT80237B (pt) 1984-04-06 1985-04-04 Processo para a metilacao selectiva de derivados de eritromicina a

Country Status (17)

Country Link
US (1) US4672109A (pt)
EP (1) EP0158467B1 (pt)
JP (1) JPS60214796A (pt)
KR (1) KR910007572B1 (pt)
AR (1) AR240833A1 (pt)
AT (1) ATE44384T1 (pt)
AU (1) AU567803B2 (pt)
CA (1) CA1225637A (pt)
DE (1) DE3571323D1 (pt)
DK (1) DK172481B1 (pt)
ES (1) ES541898A0 (pt)
FI (1) FI77250C (pt)
GE (1) GEP19960318B (pt)
HK (1) HK99694A (pt)
PT (1) PT80237B (pt)
SU (1) SU1577700A3 (pt)
ZA (1) ZA852349B (pt)

Families Citing this family (55)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS61103890A (ja) * 1984-10-26 1986-05-22 Taisho Pharmaceut Co Ltd ６−０−メチルエリスロマイシンａ誘導体
US4847242A (en) 1985-03-12 1989-07-11 Beecham Group P.L.C. 11-ether derivatives of erythromycins
GB8506380D0 (en) * 1985-03-12 1985-04-11 Beecham Group Plc Chemical compounds
US4670549A (en) * 1985-03-18 1987-06-02 Taisho Pharmaceutical Co., Ltd. Method for selective methylation of erythromycin a derivatives
US4833236A (en) * 1986-05-02 1989-05-23 Taisho Pharmaceutical Co., Ltd. Erythromycin derivatives
EP0260938B1 (en) * 1986-09-18 1992-12-09 Taisho Pharmaceutical Co. Ltd Erythromycin a derivatives and method for preparing the same
KR960000434B1 (ko) * 1986-12-17 1996-01-06 다이쇼 세이야꾸 가부시끼가이샤 에리스로마이신 a유도체 및 그의 제조 방법
JP2751385B2 (ja) * 1988-05-19 1998-05-18 大正製薬株式会社 エリスロマイシンａオキシム及びその塩の製造方法
US5302705A (en) * 1989-10-07 1994-04-12 Taisho Pharmaceutical Co., Ltd. 6-O-methylerythromycin a oxime derivatives
US5872229A (en) * 1995-11-21 1999-02-16 Abbott Laboratories Process for 6-O-alkylation of erythromycin derivatives
US5756473A (en) * 1995-11-21 1998-05-26 Abbott Laboratories 6-O-methyl erythromycin D and process for making
US5719272A (en) * 1996-04-02 1998-02-17 Abbott Laboratories 2'-protected 3'-dimethylamine, 9-etheroxime erythromycin A derivatives
US5808017A (en) * 1996-04-10 1998-09-15 Abbott Laboratories Process for preparing erythromycin A oxime
ES2173057T3 (es) 1996-07-29 2004-11-16 Abbott Laboratories Preparacion de la forma ii cristalina de claritromicina.
US5858986A (en) * 1996-07-29 1999-01-12 Abbott Laboratories Crystal form I of clarithromycin
US5945405A (en) 1997-01-17 1999-08-31 Abbott Laboratories Crystal form O of clarithromycin
US5864023A (en) * 1997-02-13 1999-01-26 Abbott Laboratories 3'-N'oxide, 3'-n-dimethylamine, 9-oxime erythromycin a derivatives
US5929219A (en) * 1997-09-10 1999-07-27 Abbott Laboratories 9-hydrazone and 9-azine erythromycin derivatives and a process of making the same
US5852180A (en) * 1997-11-17 1998-12-22 Abbott Laboratories Chemical synthesis of 6-O-alkyl erythromycin A
US5932710A (en) 1997-12-01 1999-08-03 Abbott Laboratories Process for preparing 6-O-alkyl-9-oxime erythromycin B
IL135792A0 (en) * 1997-12-01 2001-05-20 Abbott Lab 6-o-alkyl derivatives of erythronolide b
IL124084A0 (en) * 1998-04-14 1999-04-11 Chemagis Ltd Erythromycin a derivatives and methods for the preparation thereof
IL125372A0 (en) * 1998-07-15 1999-03-12 Chemagis Ltd Erythromycin derivatives and methods for the preparation thereof
KR100283990B1 (ko) * 1998-12-29 2001-03-02 민경윤 에리스로마이신 a 유도체 및 그의 제조방법
SI20150A (sl) * 1999-02-19 2000-08-31 Lek, Tovarna Farmacevtskih In Direktno stisljivi matriks za nadzorovano sproščanje celodnevne doze klaritromicina
US6437106B1 (en) 1999-06-24 2002-08-20 Abbott Laboratories Process for preparing 6-o-substituted erythromycin derivatives
KR20010008496A (ko) * 1999-07-01 2001-02-05 유충식 6-오-메틸 에리트로마이신의 제조방법
US6627743B1 (en) 1999-12-03 2003-09-30 Abbott Laboratories 6-O-methylerythromycin A crystal form III
CA2395555A1 (en) 1999-12-16 2001-06-21 Teva Pharmaceutical Industries Ltd. Processes for preparing clarithromycin polymorphs and novel polymorph iv
ES2236023T3 (es) 2000-01-11 2005-07-16 Teva Pharmaceutical Industries Ltd. Procedimiento para preparacion de polimorfos de claritromicina.
US6565882B2 (en) 2000-02-24 2003-05-20 Advancis Pharmaceutical Corp Antibiotic composition with inhibitor
US6544555B2 (en) 2000-02-24 2003-04-08 Advancis Pharmaceutical Corp. Antibiotic product, use and formulation thereof
CZ20023167A3 (cs) 2000-02-29 2003-10-15 Teva Pharmaceutical Industries Ltd. Způsob přípravy klaritromycinu a klaritromycinového meziproduktu, v podstatě prostého oximu a farmaceutický prostředek, který jej obsahuje
BR0109194A (pt) * 2000-03-15 2003-02-11 Hanmi Pharm Ind Co Ltd Método para preparar claritromicina em cristais da forma ii
CZ20023855A3 (cs) * 2000-05-15 2003-09-17 Ranbaxy Laboratories Limited Ekonomicky výhodný způsob selektivní methylace derivátů erythromycinu A
EP1313749B1 (en) * 2000-08-23 2005-10-12 Wockhardt Limited Process for preparation of anhydrous azithromycin
US20020068078A1 (en) 2000-10-13 2002-06-06 Rudnic Edward M. Antifungal product, use and formulation thereof
US6541014B2 (en) 2000-10-13 2003-04-01 Advancis Pharmaceutical Corp. Antiviral product, use and formulation thereof
CA2481271A1 (en) * 2002-04-03 2003-10-09 Ranbaxy Laboratories Limited Clarithromycin formulations having improved bioavailability
US6843854B2 (en) 2002-05-31 2005-01-18 Purdue Research Foundation Method and apparatus for separating a component from a mixture
ES2221807B1 (es) * 2003-06-24 2005-12-16 Ercros Industrial, S.A. Un procedimiento para la obtencion de claritromicina.
CA2533292C (en) 2003-07-21 2013-12-31 Advancis Pharmaceutical Corporation Antibiotic product, use and formulation thereof
AU2004258944B2 (en) 2003-07-21 2011-02-10 Shionogi, Inc. Antibiotic product, use and formulation thereof
CA2533178C (en) 2003-07-21 2014-03-11 Advancis Pharmaceutical Corporation Antibiotic product, use and formulation thereof
EP1653925A1 (en) 2003-08-11 2006-05-10 Advancis Pharmaceutical Corporation Robust pellet
JP2007502294A (ja) 2003-08-12 2007-02-08 アドバンシス ファーマスーティカル コーポレイション 抗生物質製剤、その使用法及び作成方法
WO2005023184A2 (en) 2003-08-29 2005-03-17 Advancis Pharmaceuticals Corporation Antibiotic product, use and formulation thereof
CA2538064C (en) 2003-09-15 2013-12-17 Advancis Pharmaceutical Corporation Antibiotic product, use and formulation thereof
EP1771158A4 (en) 2004-07-02 2008-03-12 Advancis Pharmaceutical Corp TABLET FOR PULSED DELIVERY
US20060111560A1 (en) * 2004-11-01 2006-05-25 Glenmark Pharmaceuticals Limited Process for the preparation of crystalline form II of clarithromycin
US8778924B2 (en) 2006-12-04 2014-07-15 Shionogi Inc. Modified release amoxicillin products
US8357394B2 (en) 2005-12-08 2013-01-22 Shionogi Inc. Compositions and methods for improved efficacy of penicillin-type antibiotics
RU2455308C2 (ru) 2006-05-01 2012-07-10 Тайсо Фармасьютикал Ко., Лтд. Макролидные производные
US8299052B2 (en) * 2006-05-05 2012-10-30 Shionogi Inc. Pharmaceutical compositions and methods for improved bacterial eradication
US20090054634A1 (en) * 2007-08-09 2009-02-26 Vinod Kumar Kansal Process for the preparation of clarithromycin

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1100504A (en) * 1967-08-16 1968-01-24 Pliva Pharm & Chem Works Erythromycin oxime and 9-amino-3-o-cladinosyl-5-o-desosaminyl-6,11,12-trihydroxy-2,4,6,8,10,12-hexamethylpentadecane-13-olide
US4166901A (en) * 1978-01-03 1979-09-04 Pfizer Inc. 4"-Deoxy-4"-arylglyoxamido- and aroylthioformamido derivatives of oleandomycin and its esters
FR2473525A1 (fr) * 1980-01-11 1981-07-17 Roussel Uclaf Nouvelles oximes derivees de l'erythromycine, leur procede de preparation et leur application comme medicaments
US4331803A (en) * 1980-06-04 1982-05-25 Taisho Pharmaceutical Co., Ltd. Novel erythromycin compounds
JPS5896095A (ja) * 1981-11-30 1983-06-07 Taisho Pharmaceut Co Ltd １１−ｏ−アルキルエリスロマイシンａ誘導体
JPS5896097A (ja) * 1981-12-01 1983-06-07 Taisho Pharmaceut Co Ltd エリスロマイシンｂ誘導体
JPS5896098A (ja) * 1981-12-03 1983-06-07 Taisho Pharmaceut Co Ltd エリスロマイシンａ誘導体
US4382085A (en) * 1982-03-01 1983-05-03 Pfizer Inc. 4"-Epi erythromycin A and derivatives thereof as useful antibacterial agents
IL75908A0 (en) * 1984-08-31 1985-12-31 Abbott Lab Macrolide alkylation process

Also Published As

Publication number Publication date
DK152385D0 (da) 1985-04-03
JPH053475B2 (pt) 1993-01-14
CA1225637A (en) 1987-08-18
FI77250C (fi) 1989-02-10
FI851376A0 (fi) 1985-04-04
HK99694A (en) 1994-09-23
SU1577700A3 (ru) 1990-07-07
JPS60214796A (ja) 1985-10-28
AU567803B2 (en) 1987-12-03
KR910007572B1 (ko) 1991-09-28
US4672109A (en) 1987-06-09
AR240833A1 (es) 1991-02-28
PT80237A (en) 1985-05-01
FI77250B (fi) 1988-10-31
ES8602839A1 (es) 1985-12-01
EP0158467A2 (en) 1985-10-16
KR850007434A (ko) 1985-12-04
GEP19960318B (en) 1996-06-24
ATE44384T1 (de) 1989-07-15
ES541898A0 (es) 1985-12-01
DK172481B1 (da) 1998-11-23
DE3571323D1 (en) 1989-08-10
ZA852349B (en) 1985-11-27
EP0158467A3 (en) 1986-03-19
EP0158467B1 (en) 1989-07-05
DK152385A (da) 1985-10-07
FI851376L (fi) 1985-10-07
AU4037885A (en) 1985-10-10

Similar Documents

Publication Publication Date Title
PT80237B (pt) Processo para a metilacao selectiva de derivados de eritromicina a
PT81859B (pt) Processo para a preparacao de derivados de tiazolidinodionas
PT81463B (pt) Processo para a preparacao de novos derivados 5-amino-4-hidroxivalerilo
PT82210B (pt) Processo para a metilacao selectiva dos derivados da eritromicina a
PT82890B (pt) Processo para a preparacao de novos derivados de n-aralquil-piperidinametanol
PT83179B (pt) Processo para a preparacao de carbinois aril-piperidinicos
PT83876B (pt) Processo para a preparacao de derivados de butiramida n-substituidos
PT82710B (pt) Processo para a preparacao de derivados la-7-substituidos de mitomicina
PT80708B (pt) Processo aperfeicoado para a preparacao de derivados de benzenossulfonamida
PT80270B (pt) Processo para a preparacao de derivados da 9a-aza-9a-homoeritromicina
PT83820B (pt) Processo para a preparacao de derivados de tioxantona
ES555646A0 (es) Un procedimiento para producir derivados de 4-0-sulfonil-uracilo
PT83344A (pt) Processo para a preparacao de ypsilon-carbolinas antipsicoticas
PT88180A (pt) Processo para a preparacao de derivados alquilaminoalcoxifenilo
PT82445B (pt) Processo para a preparacao de novos derivados glicopeptidicos
PT80264B (pt) Processo para a preparacao de derivados de hidroxi-4-2h-1-benzotiopiran-2-onas
BR8501588A (pt) Processo para a preparacao de poliisocianatos
PT82245B (pt) Processo para a preparacao de 2-amino-6-cloropurina
BR8502305A (pt) Processo para a preparacao de organopol issiloxanas organofuncionais
BR8505989A (pt) Processo para a preparacao de amino-4-difenilaminas
PT80919B (pt) Processo para a preparacao de 3-arilcarbonil e 3-cicloalquilcarbonil-1-minoalquil_1h-indois
PT85608A (pt) Processo para a preparacao de derivados de fenil-etanolamina
PT80336B (pt) Processo para a preparacao de derivados de iminotiazolidina
BR8501134A (pt) Processo para a preparacao de gliciditeres
ES557566A0 (es) Un procedimiento para preparar derivados de azirino-pirrolo-indol-diona